Impact of <i>UGT1A1*28</i> polymorphism in patients with metastatic pancreatic ductal adenocarcinoma treated with NALIRIFOX in the NAPOLI 3 trial

Maen Abdelrahim, Gazala Khan, Hassan Hatoum, Alice Zervoudakis, Farshid Dayyani, Li Zhang, Jia Li, Fiona Maxwell, Eileen M. O’Reilly, Zev A. Wainberg, Andrea Bullock

Open source

DOI: 10.1080/14796694.2026.2664776
Published: 2026-05-04
Container: Future Oncology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14796694.2026.2664776,
  title = {Impact of
                    <i>UGT1A1*28</i>
                    polymorphism in patients with metastatic pancreatic ductal adenocarcinoma treated with NALIRIFOX in the NAPOLI 3 trial},
  author = {Maen Abdelrahim and Gazala Khan and Hassan Hatoum and Alice Zervoudakis and Farshid Dayyani and Li Zhang and Jia Li and Fiona Maxwell and Eileen M. O’Reilly and Zev A. Wainberg and Andrea Bullock},
  year = {2026},
  journal = {Future Oncology},
  doi = {10.1080/14796694.2026.2664776},
  url = {https://doi.org/10.1080/14796694.2026.2664776}
}

RIS

TY  - JOUR
TI  - Impact of
                    <i>UGT1A1*28</i>
                    polymorphism in patients with metastatic pancreatic ductal adenocarcinoma treated with NALIRIFOX in the NAPOLI 3 trial
AU  - Maen Abdelrahim
AU  - Gazala Khan
AU  - Hassan Hatoum
AU  - Alice Zervoudakis
AU  - Farshid Dayyani
AU  - Li Zhang
AU  - Jia Li
AU  - Fiona Maxwell
AU  - Eileen M. O’Reilly
AU  - Zev A. Wainberg
AU  - Andrea Bullock
PY  - 2026
JO  - Future Oncology
DO  - 10.1080/14796694.2026.2664776
UR  - https://doi.org/10.1080/14796694.2026.2664776
ER  -

APA

Abdelrahim, M., Khan, G., Hatoum, H., Zervoudakis, A., Dayyani, F., Zhang, L., Li, J., Maxwell, F., O’Reilly, E. M., Wainberg, Z. A., & Bullock, A. (2026). Impact of <i>UGT1A1*28</i> polymorphism in patients with metastatic pancreatic ductal adenocarcinoma treated with NALIRIFOX in the NAPOLI 3 trial. Future Oncology. https://doi.org/10.1080/14796694.2026.2664776

Source records

crossref · retrieved 2026-09-27T00:42:15.839Z